| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.07 | 0.2 |